Tsinghua Holdings' subsidiary enterprises took quick actions to join the national efforts in fighting against the outbreak of the novel coronavirus pneumonia (NCP), also named by the WHO as COVID-19, in Wuhan city, Central China's Hubei province.

Tsinghua Unigroup and its subsidiary H3C, an industry leader in digital solutions, launched an emergency assistance project on January 24 to help tackle the epidemic. The companies donated network communication and information security products and equipment worth over 30 million yuan to Huoshenshan Hospital and Leishenshan Hospital, which were constructed in around ten days in Wuhan city, in a bid to curb the spread of the coronavirus.

Tsinghua Unigroup and H3C donate network communication and information security products and equipment to the Huoshenshan Hospital and Leishenshan Hospital.

The equipment will help the two hospitals build a high-speed, stable, and secure basic network to carry medical data and ensure information sharing and security in all wards of the two hospitals.

H3C also provided on-site equipment deployment, installation, commissioning and maintenance services, as well as remote operation.

At the onset of the COVID-19 outbreak, CapitalBio Corporation responded to the national call immediately and put serious efforts into novel coronavirus detection and research to help identify confirmed cases of COVID-19 infection.

Led by Cheng Jing, a professor of the Department of the School of Medicine, Tsinghua University, a member of the Chinese Academy of Engineering and chairman and president of CapitalBio Corporation, the company quickly deployed its testing laboratories in Beijing, Chengdu city in Sichuan province, and Dongguan city in Guangdong province, and initiated emergency preparedness.

During the Spring Festival holiday, lab workers conducted 24/7 responses to ensure sample testing at any time and issued pathogen detection reports as quickly as possible.

CapitalBio high throughput sequencing testing lab

CapitalBio also began its emergency technical research and developed a new microfluidic chip for rapid detection of multiple respiratory viruses. The chip can detect 19 kinds of common respiratory viruses including the novel coronavirus with samples of patients' pharyngeal swabs and sputum in 1.5 hours. The chip will soon be used in the clinic.

The Isothermal amplification microfluidic pathogen nucleic acid detection chip system of CapitalBio Corporation

The Dandong First Hospital under Chengzhi Holding Co., Ltd. in Dandong city, Northeast China’s Liaoning province dispatched medical workers to assist Wuhan city on Jan 25.

Medical workers of the Dandong First Hospital just before departing for Wuhan on Jan 25

Chengzhi Holdings’ subsidiary Beijing Chengzhi Shenghua Medical Equipment Technology Co., Ltd., which is specialized in medical equipment management, provided 24-hour medical equipment support services for institutions.

The services included implementing emergency modification of isolation wards, coordinating medical equipment purchase, installation, and training, delivery of protective equipment and inspection of disinfection equipment.

Tus-Medical Health Technology, a subsidiary of Tus-Holdings, organized experts to work on research and application of virus inspection technology from the start of the outbreak. The company sent technical experts to provide on-site guidance to laboratories conducting novel coronavirus tests to ensure that the latest testing technologies and platforms were being used correctly.

Workers of the Tus-Medical Health Technology in a testing laboratory

Yadu Technology, a subsidiary of Tus-Holdings specialized in air purification technology and products, donated air purifiers and KN95 masks to the Wuhan Sixth Hospital.